In humans with DN, the expression of GDF15 in plasma and urine has been discovered as a possible biomarker for early diagnosis of DN, and has been shown to independently correlate with renal risk in prior research (56–58). The gene discussed is GDF15; the disease is liver dysplastic nodule.